Home  >  News
Eppen_CellXpert_Nov24
you can get e-magazine links on WhatsApp. Click here
Product Launches + Font Resize -

Lincoln Pharma launches gatifloxacin brand for respiratory infections

Our Bureau, Mumbai
Wednesday, September 17, 2003, 08:00 Hrs  [IST]

Ahmedabad based Lincoln Pharmaceuticals Limited has launched an antibiotic, Gatilink for respiratory infected patients. Gatilink (gatifloxacin) is the latest drug approved by US FDA and is very well recommended by medical fraternity according to Dr. Sanjay Agrawal (GM) Medical Services.

Gatilink is also effective in TB cases who have developed resistance to conventional therapy. According to Rajani.G.Patel, Jt. Managing Director, this product is available now at all retail counters with both the strengths.

Recent studies indicated that respiratory infections are on rise due to pollution and decline of greeneries, this has led to 15 to 20 per cent rise in RTI cases.

 




*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
 
avians24_PB
PharmaTech_Lab_expo25
Asia_Lab_Expo2025
                                                         
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram